Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,176,969
-
Share change
-
+532,455
-
Total reported value
-
$73,600,605
-
Put/Call ratio
-
137%
-
Price per share
-
$10.25
-
Number of holders
-
71
-
Value change
-
+$4,766,747
-
Number of buys
-
39
-
Number of sells
-
32
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q4 2017
As of 31 Dec 2017,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,176,969 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., Vanguard Group Inc, TIAA CREF INVESTMENT MANAGEMENT LLC, Rubric Capital Management LP, FRANKLIN RESOURCES INC, Newtyn Management, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.